PRF Technologies Ltd (PRFX)

NASD · Healthcare · Drug Manufacturers - Specialty & Generic · Israel

PRF Technologies Ltd is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.

Intrinsic value, DCF valuation, financial health and value investing analysis for the PRF Technologies Ltd stock.

Our verdict on PRFX

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover one fiscal year and projecting growth needs four in a row.

Browse

Peers in Drug Manufacturers - Specialty & Generic

All 84 Drug Manufacturers - Specialty & Generic stocks

Cheaper than PRFX in Drug Manufacturers - Specialty & Generic

35 more in this industry show a wider margin of safety.

Is PRFX undervalued or overvalued?

We do not publish a verdict on PRFX yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover one fiscal year so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of PRFX?

We do not publish one (as of the 2026-10-30 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover one fiscal year so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.